Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma (Q42484966)

1 November 2017

Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma (English)

1 reference

1 November 2017

1 reference

8

Renata Pasqualini

1 reference

1 November 2017

9

Wadih Arap

1 reference

1 November 2017

Michael G Ozawa

1

1 reference

1 November 2017

Virginia J Yao

2

1 reference

1 November 2017

Yvan H Chanthery

3

1 reference

1 November 2017

Patricia Troncoso

4

1 reference

1 November 2017

Akiyoshi Uemura

5

1 reference

1 November 2017

Amanda S Varner

6

1 reference

1 November 2017

Ian M Kasman

7

1 reference

1 November 2017

Donald M McDonald

10

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

1 November 2017

1 reference

1 November 2017

104

1 reference

1 November 2017

10

1 reference

1 November 2017

2104-2115

1 reference

Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors

1 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

Molecular profiling of angiogenesis markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

Decreasing mortality rates for prostate cancer: possible role of hormonal therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Histologic grading of prostate cancer: a perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Contemporary pathology of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Molecular regulation of vessel maturation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

The role of angiogenesis in prostate development and the pathogenesis of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Plasma angiopoietin‐1, angiopoietin‐2 and Tie‐2 in breast and prostate cancer: a comparison with VEGF and Flt‐1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

VEGF and the quest for tumour angiogenesis factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Pericyte loss and microaneurysm formation in PDGF-B-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Microvessel density in prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Prostate cancer in a transgenic mouse

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Pathologic progression of autochthonous prostate cancer in the TRAMP model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Aminopeptidase A is a functional target in angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

The role of the microenvironment and intercellular cross-talk in tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21436

7 January 2021

Identifiers

DOI

10.1002/CNCR.21436

1 reference

1 November 2017

1 reference